Skip to main content
. 2021 May 2;10(5):523. doi: 10.3390/antibiotics10050523

Table 3.

Gram-negative uropathogen resistance profiles.

Antibiotics Gram-Negative Organisms Isolated
Escherichia coli Klebsiella spp. Pseudomonas aeruginosa Proteus spp. Total
R S NA R S NA R S NA R S NA R S NA
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n % n %
Amikacin 84 (29.68) 189 (66.78) 10 (3.53) 138 (53.07) 120 (46.15) 2 (0.76) 53 (88.33) 6 (10.0) 1 (1.66) 14 (34.14) 27 (65.85) - 289 (44.87) 342 (53.1) 13 (2.01)
Amoxicillin-
Clavulanic ac.
161 (56.89) 114 (40.28) 8 (2.82) 246 (94.61) 11 (4.23) 3 (1.15) - - - 33 (80.48) 7 (17.07) 1 (2.43) 440 (75.34) 132 (22.6) 12 (2.05)
Ampicillin 189 (66.78) 6 (2.12) 88 (31.09) - - - - - - 23 (56.09) 2 (4.87) 16 (39.02) 212 (65.43) 8 (2.46) 104 (32.09)
Aztreonam - - - 108 (41.53) 3 (1.15) 149 (57.3) 18 (30.0) 2 (3.33) 40 (66.66) 11 (26.82) 6 (14.63) 24 (58.53) 137 (37.95) 11 (3.04) 213 (59.0)
Trimethoprim/
Sulfamethoxazole
141 (49.82) 58 (20.49) 84 (29.68) 102 (39.23) 35 (13.46) 123 (47.3) 7 (11.66) 1 (1.66) 52 (86.66) 20 (48.78) 4 (9.75) 17 (41.46) 270 (41.92) 98 (15.21) 276 (42.85)
Ceftazidime 170 (60.07) 101 (35.68) 12 (4.24) 245 (94.23) 14 (5.38) 1 (0.38) 54 (90.0) 6 (10.0) 0 34 (82.92) 6 (14.63) 1 (2.43) 503 (78.10) 127 (19.72) 14 (2.17)
Fosfomycin 20 (7.06) 237 (83.74) 26 (9.18) 41 (15.76) 60 (23.07) 159 (61.15) - - - 10 (24.39) 6 (14.63) 25 (60.97) 71 (12.15) 303 (51.88) 210 (35.95)
Imipenem 2 (0.7) 81 (28.62) 200 (70.67) 55 (21.15) 136 (52.3) 69 (26.53) 45 (75.0) 6 (10.0) 9 (15.0) 4 (9.75) 12 (29.26) 25 (60.97) 106 (16.45) 235 (36.49) 303 (47.04)
Levofloxacin 204 (72.08) 47 (16.6) 32 (11.30) 166 (63.84) 68 (26.15) 26 (10.0) 58 (96.66) 1 (1.66) 1 (1.66) 24 (58.53) 10 (24.39) 7 (17.07) 452 (70.18) 126 (19.56) 66 (10.24)
Meropenem 2 (0.7) 86 (30.38) 195 (68.90) 61 (23.46) 145 (55.76) 54 (20.76) 42 (70.0) 10 (16.66) 8 (13.33) 5 (12.19) 27 (65.85) 9 (21.95) 110 (17.08) 268 (41.61) 266 (41.3)
Nitrofurantoin 47 (16.6) 111 (39.22) 125 (44.16) 57 (21.92) 38 (14.61) 165 (63.46) 8 (13.33) 5 (8.33) 47 (78.33) - - - 112 (18.57) 154 (25.53) 337 (55.88)

n—number, %—percentage; R—resistant, S—sensitive, and NA—not available.